Asm. Andrew Hevesi

Maddy summaryThis bill (A 10310) requires residential health care facilities to maintain written agreements with licensed hospice programs. It directly affects facilities caring for residents eligible for hospice services, mandating coordination on key areas like timely referrals, care planning, medication management, and emergency response. The agreements must address six specific coordination points, including roles of facility and hospice staff and after-hours communication. Facilities that fail to comply face enforcement under health law, and the Department of Health will provide implementation guidance and model contracts.

Provides that beginning in the 2026-2027 academic year, certain graduate students shall be required to pay 25% of all current and future mandatory university fees; provides that in the 2027-2028 academic year and thereafter, no mandatory university fees shall be charged to certain graduate students and adjunct staff, with the exclusion of the graduate student association student activity fee.

Establishes a developmental disability, mental health, and behavioral condition community stakeholder committee to examine effective evidence-based developmental, mental, and behavioral health screening methods for children in kindergarten through fifth grade.

Establishes maximum contaminant levels in drinking water for certain per- and polyfluoroalkyl substances (PFAS); sets such levels at no higher than 4 parts per trillion (ppt) for perfluorooctane sulfonic acid (PFOS) and perfluorooctanoic acid (PFOA) and no higher than 10 parts per trillion (ppt) for perfluorononanoic acid (PFNA), perfluorohexane sulfonate (PFHxS), and hexafluoropropylene oxide dimer acid (HFPO-DA).

Establishes an indirect source review for heavy distribution warehouse operations; requires the department of environmental conservation to conduct a study regarding zero-emissions zones.

Maddy summaryThis bill requires New York's Office for People with Developmental Disabilities to submit updated waitlist and placement reports twice yearly (every six months) to the Senate and Assembly leadership. The reports must include detailed data on individuals awaiting residential placement (broken down by age, medical needs, and placement type), actual placements made, costs, funding sources, and projections for future needs over five years. It specifically mandates information on individuals in inadequate living situations, failed placements, and plans to address gaps in service. The goal is to provide legislators with transparent, data-driven insights into the state's developmental disability service system.

Provides that certain purchase contracts to purchase food can be awarded to a qualified bidder who fulfills certain values based procurement standards when such bid is not more than 10% higher than the lowest responsible bidder and when the bidder makes publicly available data on where such bidder sources their food items; sets forth the criteria for values based procurement standards to include local economies, environmental resilience, racial equity, valued workforce, valued agricultural sector, animal welfare, and nutrition.

Provides that no state or local correctional facility shall deny entry to a person visiting such facility due to the fact that such person is menstruating or has a contraceptive device or appears on body scan imaging or alternative methods to have or be using a menstrual product or contraceptive device.

Enacts the empire state licensing act to provide all New Yorkers with access to professional, occupational, commercial, or business licenses, permits, certificates, or related registrations regardless of an applicant's citizenship or immigration status.

Maddy summaryThis New York bill prohibits the sale of products containing 7-hydroxymitragynine (a compound found in some kratom products) when concentrated above 400 parts per million. It directly affects businesses - including stores, online platforms, and other sellers - operating within New York State that sell such products. The law imposes civil fines of up to $3,000 for a first violation and $6,500 for repeat offenses, with collected funds directed to New York's drug treatment and public education programs. The bill defines prohibited products broadly to include any substance, extract, or finished good containing the compound at the specified level.